Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Internet Cognitive Behavior Therapy (CBT) for Obsessive Compulsive Disorder (OCD) [NA]
A clinical trial evaluating Internet-based Cognitive Behavioral Therapy for Obsessive Compulsive Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD) [Phase 3]
Phase 3 trial evaluating D-cycloserine augmentation of CBT for pediatric obsessive-compulsive disorder has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Deep Brain Stimulation for Obsessive Compulsive Disorder (OCD PMCF) [Phase 4]
Phase 4 clinical trial update on deep brain stimulation for obsessive compulsive disorder (OCD) completed.
-
CLINICAL_TRIALS research · 2017-12-12Clinical Trial Update: What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder [NA]
This update concerns a study on reassurance-seeking in obsessive-compulsive disorder with psychometric and experimental analyses. The trial …
-
FDA approval · 2017-12-08FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sertraline hydrochloride submitted by Mylan Pharmaceuticals, likely affecting the product la…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder [Phase 3]
This publication reports the completion and posting of results from a Phase 3 trial evaluating fluvoxamine for obsessive-compulsive disorder…
-
FDA approval · 2017-11-20FDA Approved: FLUOXETINE — Original Application (NIVAGEN PHARMACEUTICALS, INC.)
FDA approved NIVAGEN Pharmaceuticals' original application for fluoxetine hydrochloride, granting marketing approval for a generic version o…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Combining Acceptance and Commitment Therapy With Exposure and Response Prevention to Enhance Treatment Engagement [NA]
A completed clinical trial evaluating combining Acceptance and Commitment Therapy with Exposure and Response Prevention to enhance treatment…
-
FDA approval · 2017-11-16FDA Approved: FLUOXETINE — Original Application (Endo USA, Inc.)
FDA approves Endo USA, Inc.'s original application for a generic fluoxetine product.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Neural Links Between OCD and Anorexia
A completed Stanford-sponsored clinical trial investigated neural links between obsessive-compulsive disorder and anorexia nervosa.
-
CLINICAL_TRIALS research · 2017-11-06Clinical Trial Update: Effects of Transcranial Direct Current Stimulation (tDCS) on Individuals With Prader-Willi Syndrome [NA]
A clinical trial update examines the effects of transcranial direct current stimulation (tDCS) in individuals with Prader-Willi syndrome, in…
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment [Phase 4]
This completed Phase 4 clinical trial investigates augmenting treatment with a drug for obsessive-compulsive disorder patients who did not r…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder Patients [Phase 4]
Phase 4 trial comparing adding quetiapine to an SSRI versus adding clomipramine to an SSRI in obsessive-compulsive disorder patients has com…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders [NA]
This clinical trial evaluating computer-assisted cognitive-behavioral therapy for anxiety disorders in children with autism spectrum disorde…
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: Randomized Controlled Meditation Trial for Treating OCD [NA]
The randomized controlled meditation trial for obsessive-compulsive disorder sponsored by the University of Sao Paulo has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Genetics of Obsessive-Compulsive Disorder
A completed clinical trial sponsored by the National Institute of Mental Health investigating the genetics of Obsessive-compulsive disorder.
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Metacognitive Therapy for Patients With Obsessive-Compulsive Disorder [NA]
Clinical trial update indicating a completed study evaluating metacognitive therapy for obsessive-compulsive disorder.
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder [Phase 1, Phase 2]
Clinical trial investigating intravenous ketamine for obsessive-compulsive disorder across Phase 1 and Phase 2; the study was terminated wit…
-
FDA approval · 2017-08-18FDA Approved: PAROXETINE — Original Application (Solco Healthcare LLC)
FDA approves the original generic application for Paroxetine (Solco Healthcare LLC).
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Development of a Behavioral Team Intervention for Obsessive Compulsive Disorder [NA]
This document reports the completion of a clinical trial evaluating a behavioral team intervention for Obsessive-Compulsive Disorder.
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Safety and Effectiveness of Gamma Capsulotomy in Intractable OCD [NA]
A completed clinical trial evaluated the safety and effectiveness of gamma capsulotomy for intractable obsessive-compulsive disorder. No spe…
-
FDA approval · 2017-08-03FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Sertraline Hydrochloride submitted by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson's Disease
A completed Mayo Clinic study used functional MRI during deep brain stimulation to examine brain activity and its relation to movement disor…
-
CLINICAL_TRIALS research · 2017-08-03Clinical Trial Update: Influence of Pregnenolone on Exposure Therapy in Obsessive-compulsive Disorder [Phase 2]
A Phase 2 clinical trial is evaluating whether pregnenolone enhances exposure therapy for obsessive-compulsive disorder. The status is curre…
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD) [Phase 2]
This document reports on a Phase 2 clinical trial of Bitopertin (RO4917838) in combination with SSRIs for obsessive-compulsive disorder. The…